… an assistant professor of medicine in the division of … of the TRIPLE-SWITCH trial, a phase 3 … multiple trials—including TITAN (apalutamide [Erleada]), LATITUDE (abiraterone acetate [Zytiga]), … , Sokolova argues that treatment intensification is warranted before …

… Arvinas Therapeutics, a biotech company developing drugs based on a … pairs the active pharmaceutical ingredient in Zytiga with niraparib, a … executive vice president, innovative medicine, R&D at … longer respond to standard treatments using a novel mechanism …

… data; pharmaceuticals database, for information on drug prescriptions, … -reported data stating that 42% … indicazioni terapeutiche del medicinale per uso umano «Zytiga» (abiraterone acetato … cancer treatment: a review of literature and ongoing trials. Discov …

… for a waiver of clinical trial (CT) study before the … a Phase IV clinical trial to evaluate the product … the Phase IV Clinical Trial protocol within three months … Zytiga, is an androgen biosynthesis inhibitor (CYP17 inhibitor) indicated for the treatment …

Medication burden, characterized by polypharmacy and suboptimal treatment adherence, is a predictor … patients prescribed oral ARSIs abiraterone (Zytiga; Yonsa), enzalutamide (Xtandi), or … interactions between ARSIs and other drug classes, which could also …

… treatment intensity with patient tolerability, and integrating emerging evidence from pivotal trials … coupled with minimal drug–drug interactions, makes … abiraterone acetate (Zytiga)—featured prominently in … intervention, including medication adjustment or …

… trial for mHSPC? Cora N. Sternberg, MD: [In terms of] treatment … tests, like abiraterone [Zytiga], and decreased neutrophils … Pharma, Genzyme, Foundation Medicine, Bristol Myers Squibb… .fda.gov/drugs/;resources-information-approved-drugs/fda- …

… & Johnson's Zytiga brand and generics – under new … on the drug as a first-line treatment for newly … reinvested in "breakthrough treatments and care improvements," … seizing the opportunity of generic medicines that deliver better value, …

… 2025 European Society for Medical Oncology (ESMO) Congress … also several notable trials in kidney cancer, … treatment decision-making and meaningfully improve outcomes in MIBC.6 Trial … trial showed that adding capivasertib (Truqap) to abiraterone acetate (Zytiga …

… S. Food and Drug Administration ("FDA") has granted … potential best-in-class medicines for patients with … treatment of TED, including two ongoing global phase 3 pivotal clinical trials … a pioneer in global pharmaceutical royalty monetization. Since …